Drugs / Beautifil II
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT07457749 Comparator | Feb 2026 → Feb 2028 expected | — | British University In Egypt | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beautifil II | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07457749 ↗ |
| Modality | Other / unclassified | “Beautifil II is a light-cured bioactive nanohybrid resin composite restorative material.” NCT07457749 ↗ |